HK1075664A1 - Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders - Google Patents

Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders

Info

Publication number
HK1075664A1
HK1075664A1 HK05110023A HK05110023A HK1075664A1 HK 1075664 A1 HK1075664 A1 HK 1075664A1 HK 05110023 A HK05110023 A HK 05110023A HK 05110023 A HK05110023 A HK 05110023A HK 1075664 A1 HK1075664 A1 HK 1075664A1
Authority
HK
Hong Kong
Prior art keywords
disorders
piperazine
treatment
benzothiazoles
agents
Prior art date
Application number
HK05110023A
Other languages
English (en)
Inventor
Pascale Gaillard
Jean-Pierre Gotteland
Pierre-Alain Vitte
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of HK1075664A1 publication Critical patent/HK1075664A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK05110023A 2002-04-25 2005-11-10 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders HK1075664A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02100417 2002-04-25
PCT/EP2003/004323 WO2003091249A1 (en) 2002-04-25 2003-04-25 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders

Publications (1)

Publication Number Publication Date
HK1075664A1 true HK1075664A1 (en) 2005-12-23

Family

ID=29265991

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05110023A HK1075664A1 (en) 2002-04-25 2005-11-10 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders

Country Status (23)

Country Link
US (1) US7314878B2 (sr)
EP (1) EP1501828B1 (sr)
JP (1) JP4523289B2 (sr)
KR (1) KR100948469B1 (sr)
CN (1) CN1310911C (sr)
AT (1) ATE383356T1 (sr)
AU (1) AU2003233067B2 (sr)
BR (1) BRPI0309594A8 (sr)
CA (1) CA2481763C (sr)
CY (1) CY1107204T1 (sr)
DE (1) DE60318567T2 (sr)
DK (1) DK1501828T3 (sr)
EA (1) EA009682B1 (sr)
ES (1) ES2297165T3 (sr)
HK (1) HK1075664A1 (sr)
IL (2) IL164796A0 (sr)
MX (1) MXPA04010474A (sr)
PT (1) PT1501828E (sr)
RS (1) RS51407B (sr)
SI (1) SI1501828T1 (sr)
UA (1) UA78035C2 (sr)
WO (1) WO2003091249A1 (sr)
ZA (1) ZA200408023B (sr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1310911C (zh) 2002-04-25 2007-04-18 应用研究系统Ars股份公司 作为脑缺血性疾病和cns疾病治疗剂的哌嗪苯并噻唑
DK1696909T3 (da) * 2003-09-12 2008-01-02 Serono Lab Benzothiazolderivater til behandling af diabetes
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
KR101337726B1 (ko) * 2004-11-17 2013-12-12 아레스 트레이딩 에스.에이. 벤조티아졸 제제 및 그것의 용도
US7838522B2 (en) 2004-11-17 2010-11-23 Ares Trading S.A. Benzothiazole formulations and use thereof
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) * 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
EP2137173A2 (en) * 2007-04-17 2009-12-30 Laboratoires Serono SA Process for the preparation of piperazine benzothiazoles
JP5329648B2 (ja) * 2008-05-16 2013-10-30 エフ．ホフマン−ラ ロシュ アーゲー Ｊｎｋの阻害剤
WO2011151358A1 (en) * 2010-06-04 2011-12-08 F. Hoffmann-La Roche Ag 2 -amino- pyrimidine derivatives useful as inhibitors of jnk
US8471027B2 (en) * 2011-04-06 2013-06-25 Hoffmann-La Roche Inc. Adamantyl compounds
WO2014114186A1 (zh) * 2013-01-24 2014-07-31 山东亨利医药科技有限责任公司 Jnk抑制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4153574B2 (ja) 1997-09-10 2008-09-24 トーアエイヨー株式会社 新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤
EP1110957A1 (en) * 1999-12-24 2001-06-27 Applied Research Systems ARS Holding N.V. Benzazole derivatives and their use as JNK modulators
EP1193256A1 (en) 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
CN1310911C (zh) 2002-04-25 2007-04-18 应用研究系统Ars股份公司 作为脑缺血性疾病和cns疾病治疗剂的哌嗪苯并噻唑

Also Published As

Publication number Publication date
RS51407B (sr) 2011-02-28
KR20040104572A (ko) 2004-12-10
RS92804A (en) 2006-12-15
DE60318567T2 (de) 2009-02-19
CA2481763C (en) 2011-06-14
CA2481763A1 (en) 2003-11-06
AU2003233067A1 (en) 2003-11-10
PT1501828E (pt) 2008-02-11
EA200401423A1 (ru) 2005-04-28
DE60318567D1 (de) 2008-02-21
JP4523289B2 (ja) 2010-08-11
US20050261304A1 (en) 2005-11-24
EP1501828B1 (en) 2008-01-09
CY1107204T1 (el) 2012-11-21
IL164796A (en) 2013-02-28
CN1310911C (zh) 2007-04-18
BRPI0309594A2 (pt) 2016-11-16
IL164796A0 (en) 2005-12-18
AU2003233067B2 (en) 2009-01-08
ZA200408023B (en) 2005-11-30
MXPA04010474A (es) 2004-12-13
CN1662528A (zh) 2005-08-31
EP1501828A1 (en) 2005-02-02
ATE383356T1 (de) 2008-01-15
DK1501828T3 (da) 2008-03-10
US7314878B2 (en) 2008-01-01
WO2003091249A1 (en) 2003-11-06
EA009682B1 (ru) 2008-02-28
KR100948469B1 (ko) 2010-03-17
SI1501828T1 (sl) 2008-04-30
JP2006504631A (ja) 2006-02-09
ES2297165T3 (es) 2008-05-01
UA78035C2 (en) 2007-02-15
BRPI0309594A8 (pt) 2017-04-11

Similar Documents

Publication Publication Date Title
CY1107204T1 (el) Πιπεραζινοβενζοθειαζολια ως ουσιες για την θεραπευτικη αντιμετωπιση εγκεφαλικων ισχαιμικων διαταραχων ή διαταραχων του κνς
ATE524169T1 (de) Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit
MX2007012374A (es) Metodos y composiciones para el tratamiento de condiciones relacionadas con cns.
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
MY135841A (en) Novel benzodioxoles
DK1242415T3 (da) 3-thiazol-4-yl-pyrolidinderivater som AMP-specifikke phosphodiesteraseinhibitorer
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
EP4100403A4 (en) 3-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONINERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
WO2005117979A3 (en) Use of il-17 in the treatment of fertility-related disorders
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
MX2007006754A (es) Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos.
GB0407025D0 (en) Novel compounds
MY136138A (en) Hexacyclic compounds
NO20050146D0 (no) N,N-disubstituerte diazocykloalkaner nyttige i behandling av CNS-forstyrrelser grunnet serotonergisk dysfunksjon
TNSN05154A1 (en) Use of levocetirizine for the treatment of persistent allergic rhinitis
EA200200750A1 (ru) Новое терапевтическое применение еноксапарина
MY135649A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130425